Cargando…

Residual Viremia in Treated HIV(+) Individuals

Antiretroviral therapy (ART) effectively controls HIV infection, suppressing HIV viral loads. However, some residual virus remains, below the level of detection, in HIV-infected patients on ART. The source of this viremia is an area of debate: does it derive primarily from activation of infected cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conway, Jessica M., Perelson, Alan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703306/ https://www.ncbi.nlm.nih.gov/pubmed/26735135 http://dx.doi.org/10.1371/journal.pcbi.1004677

Ejemplares similares

Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients
por: Hofstra, Laura Marije, et al.
Publicado: (2014)

Replicate Aptima Assay for Quantifying Residual Plasma Viremia in Individuals on Antiretroviral Therapy
por: Bakkour, Sonia, et al.
Publicado: (2020)

Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers
por: Conway, Jessica M., et al.
Publicado: (2019)

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
por: Aamer, Hadega A., et al.
Publicado: (2020)

Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy
por: Weissmann, Leonardo, et al.
Publicado: (2019)

Impact of Different Oseltamivir Regimens on Treating Influenza A Virus Infection and Resistance Emergence: Insights from a Modelling Study
por: Canini, Laetitia, et al.
Publicado: (2014)

Low-level residual viremia and risk of virological failure
por: Cologni, G, et al.
Publicado: (2010)

HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
por: Widera, Marek, et al.
Publicado: (2017)

Impact of Chemotherapy for HIV-1 Related Lymphoma on Residual Viremia and Cellular HIV-1 DNA in Patients on Suppressive Antiretroviral Therapy
por: Cillo, Anthony R., et al.
Publicado: (2014)

HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy
por: Mavigner, Maud, et al.
Publicado: (2009)

A Hepatitis C Virus Infection Model with Time-Varying Drug Effectiveness: Solution and Analysis
por: Conway, Jessica M., et al.
Publicado: (2014)

Automated Multireplicate Quantification of Persistent HIV-1 Viremia in Individuals on Antiretroviral Therapy
por: Jacobs, Jana L., et al.
Publicado: (2020)

Reduced adherence to antiretroviral therapy is associated with residual low-level viremia
por: Maggiolo, Franco, et al.
Publicado: (2017)

Unified model of short- and long-term HIV viral rebound for clinical trial planning
por: Conway, Jessica M., et al.
Publicado: (2021)

Persistent HIV Viremia: Description of a Cohort of HIV Infected Individuals with ART Failure in Puerto Rico
por: Maldonado-Martínez, Gerónimo, et al.
Publicado: (2015)

Association of Residual Plasma Viremia and Intima-Media Thickness in Antiretroviral-Treated Patients with Controlled Human Immunodeficiency Virus Infection
por: Boyd, Anders, et al.
Publicado: (2014)

Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection
por: Archin, Nancie M., et al.
Publicado: (2010)

The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
por: Gandhi, Rajesh T., et al.
Publicado: (2010)

Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV
por: Mellberg, Tomas, et al.
Publicado: (2011)

Comparison of Roche TaqMan v.2.0, Abbott RealTime and Modified Abbott Residual Viremia Assays in Testing of Routine Samples for Viremia Monitoring in HIV Care
por: Mckinnon, John, et al.
Publicado: (2017)

Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus Population
por: Immonen, Taina T., et al.
Publicado: (2015)

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection
por: Goonetilleke, Nilu, et al.
Publicado: (2009)

Clonally expanded HIV-1 proviruses with 5′-leader defects can give rise to nonsuppressible residual viremia
por: White, Jennifer A., et al.
Publicado: (2023)

HIV-DNA in the Genital Tract of Women on Long-Term Effective Therapy Is Associated to Residual Viremia and Previous AIDS-Defining Illnesses
por: Prazuck, Thierry, et al.
Publicado: (2013)

Impact of Low-Level-Viremia on HIV-1 Drug-Resistance Evolution among Antiretroviral Treated-Patients
por: Delaugerre, Constance, et al.
Publicado: (2012)

Patterns of HIV viremia and viral suppression before diagnosis of non-AIDS-defining cancers in HIV-infected individuals
por: Riedel, David J., et al.
Publicado: (2015)

Viral and Host Mediators of Non-Suppressible HIV-1 Viremia
por: Mohammadi, Abbas, et al.
Publicado: (2023)

Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals
por: Toyoda, Mako, et al.
Publicado: (2020)

Transient Erythema Elevatum Diutinum Associated With HIV Viremia
por: Rashdan, Hannah, et al.
Publicado: (2023)

PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia
por: Peligero, Cristina, et al.
Publicado: (2015)

Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study
por: Estébanez, Miriam, et al.
Publicado: (2014)

Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy
por: Younas, Mehwish, et al.
Publicado: (2021)

Bocavirus viremia
por: Sukkaromdee, Pathoom, et al.
Publicado: (2015)

Correction: The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
por: Gandhi, Rajesh T., et al.
Publicado: (2011)

Association of Low Level Viremia with Inflammation and Mortality in HIV-Infected Adults
por: Eastburn, Abigail, et al.
Publicado: (2011)

VIREMIA IN HUMAN POLIOMYELITIS
por: Horstmann, Dorothy M., et al.
Publicado: (1954)

No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized Trial
por: Li, Jonathan Z, et al.
Publicado: (2019)

Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala
por: Ortíz, Dean W., et al.
Publicado: (2021)

Hepatitis C Viremia Is Associated with Cytomegalovirus IgG Antibody Levels in HIV-Infected Women
por: Kuniholm, Mark H., et al.
Publicado: (2013)

Viremia Trajectories of HIV in HIV-Positive Women in the United States, 1994-2017
por: Kassaye, Seble G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i4likevdfi5f84t389l08r1hth